Why Retailers Are Looking for a New Cannabinoid Alternative
The European cannabinoid market has changed rapidly. In recent years, certain cannabinoids became restricted in multiple countries. As a result, many retailers were forced to remove products from their shelves, even though consumer demand did not disappear.
Customers are still looking for products that deliver a noticeable cannabinoid effect. However, retailers now need a solution that fits within current regulations. This shift created a clear need for a structured and compliant alternative.
AJ-1 and AJ-2 were developed in response to this new market reality.
What Are AJ-1 and AJ-2?
AJ-1 and AJ-2 are proprietary cannabinoid blends developed for the Happy Bites product line. They are designed specifically for structured retail distribution within today’s legal framework.
AJ-1 contains cannabidiol (CBD) as part of its formulation. Because of this, it offers a more balanced and controlled profile within the range.
AJ-2 does not contain CBD. It is positioned as the more pronounced option, designed for customers who are looking for a stronger cannabinoid experience.
Both blends are carefully formulated, clearly defined and not based on temporary market trends. They represent a long-term solution for retailers who want stability.
A Structured Alternative Within European Regulations
AJ-1 and AJ-2 are developed within the legal framework of the Netherlands and almost every European country. At the time of writing, Austria is the only known exception.
This positioning is important. Retailers need clarity before adding new cannabinoid products to their portfolio. AJ-1 and AJ-2 were created to operate within existing regulatory boundaries rather than pushing legal grey areas.
However, as with all cannabinoid legislation, regulations may change and can differ between regions. Therefore, distributors and retailers should always verify local compliance before entering new markets.
What Effects Can Retailers Position AJ-1 and AJ-2 For?
AJ-1 and AJ-2 are designed to deliver a noticeable cannabinoid effect. Many partners position them as a modern alternative for customers who previously purchased high-style cannabinoid products.
It is important to understand that AJ-1 and AJ-2 are proprietary blends with their own defined profiles. While some users describe the experience as comparable to traditional THC-style effects, they are not identical formulations. Instead, they offer a structured and regulated alternative within current European compliance standards.
For retailers, this means they can continue to serve demand without relying on restricted substances.
Compliance, Testing and Available Documentation
In the current European market, clarity around product composition and testing is increasingly important. Retailers want to understand what they are selling and under which framework a product operates.
AJ-1 and AJ-2 are produced under controlled conditions and each production batch is analysed by an independent laboratory. These analyses verify composition and help ensure batch consistency. Certificates of Analysis and laboratory documentation are available upon request.
This allows distributors and retailers to request supporting documents when needed, whether for internal review, regulatory checks or market entry requirements. Having access to clear documentation makes the product easier to position and distribute responsibly.
Why Retailers Are Transitioning to AJ-1 and AJ-2
After recent regulatory changes, many retailers found themselves without a stable cannabinoid option that could remain on the shelf long term. At the same time, consumer demand for noticeable cannabinoid effects has continued.
AJ-1 and AJ-2 offer a structured alternative within the current legal framework. They are not positioned as temporary workarounds, but as clearly defined blends with controlled formulation and testing.
For retailers, this means fewer uncertainties around supply and formulation, and more clarity about how the product fits within today’s regulatory environment.
A Good Alternative in a Changing Market
The European cannabinoid sector continues to evolve. As certain cannabinoids disappear from the market, retailers and consumers actively look for a compliant option that delivers a comparable experience within today’s legal framework.
AJ-1 and AJ-2 were developed to meet that demand. They offer a defined cannabinoid profile designed to provide effects that many users describe as similar in feel and intensity to previous market favorites, while remaining aligned with current legislation in the Netherlands and almost every European country, with Austria currently being the known exception.
For wholesale and retail partners, the focus is clear: offer a product that responds to ongoing consumer demand for a noticeable cannabinoid experience, while operating within existing legal boundaries and supported by transparent documentation.
